[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations]

Dtsch Med Wochenschr. 2011 Dec;136(49):2554-9. doi: 10.1055/s-0031-1292822. Epub 2011 Nov 30.
[Article in German]
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use
  • Calcineurin Inhibitors*
  • Contraindications
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Substitution*
  • Graft Rejection / drug therapy
  • Graft Rejection / immunology*
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Function Tests
  • Kidney Transplantation / immunology*
  • Neoplasms / drug therapy
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Sirolimus / adverse effects
  • Sirolimus / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Sirolimus